RNS Number : 0870Q Stifel Nicolaus Europe Limited 28 May 2024   FORM 8.5 (EPT/RI)   PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY Rule 8.5 of the Takeover Code (the "Code")   1.         KEY INFORMATION   (a) Name of

RNS Number : 9642P Renalytix PLC 28 May 2024   Renalytix plc ("Renalytix" or the "Company")   Management Change   LONDON and SALT LAKE CITY -   28 May 2024   -   Renalytix plc   (NASDAQ: RNLX) (LSE: RENX)   announces that O. James Sterling will step down from his role as Chief Financial Officer of

RNS Number : 4592P Stifel Nicolaus Europe Limited 22 May 2024   FORM 8.5 (EPT/RI)   PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY Rule 8.5 of the Takeover Code (the "Code")   1.         KEY INFORMATION   (a) Name of

RNS Number : 1850P Renalytix PLC 21 May 2024   Renalytix plc ("Renalytix" or the "Company")   Block Admission and "At The Market" Sales Agreement LONDON and SALT LAKE CITY -   21 May 2024   -   Renalytix plc   (NASDAQ: RNLX) (LSE: RENX)   entered into an at-the-market offering agreement with H.C.

RNS Number : 0777P Stifel Nicolaus Europe Limited 20 May 2024   FORM 8.5 (EPT/RI)   PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY Rule 8.5 of the Takeover Code (the "Code")   1.         KEY INFORMATION   (a) Name of

RNS Number : 9654O Renalytix PLC 17 May 2024   FORM 8.3   PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the "Code")   1.         KEY INFORMATION   (a) Full name of discloser: DB Capital

RNS Number : 9105O Stifel Nicolaus Europe Limited 17 May 2024   FORM 8.5 (EPT/RI)   PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY Rule 8.5 of the Takeover Code (the "Code")   1.         KEY INFORMATION   (a) Name of

RNS Number : 7255O Stifel Nicolaus Europe Limited 16 May 2024   FORM 8.5 (EPT/RI)   PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY Rule 8.5 of the Takeover Code (the "Code")   1.         KEY INFORMATION   (a) Name of

RNS Number : 7210O Stifel Nicolaus Europe Limited 16 May 2024   FORM 8.5 (EPT/RI)   PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY Rule 8.5 of the Takeover Code (the "Code")   1.         KEY INFORMATION   (a) Name of

RNS Number : 5079O Renalytix PLC 15 May 2024   Renalytix plc ("Renalytix" or the "Company")   Renalytix Reports Financial Results for Third Quarter of Fiscal Year 2024   LONDON and NEW YORK , May 15, 2024   - Renalytix plc (NASDAQ: RNLX) (LSE: RENX), an artificial intelligence-enabled in vitro